“Back to the Future”: Developments in Immunotherapy with David Gandara, MD

‍

In this episode, host Shikha Jain, MD, speaks with David Gandara, MD, about how ctDNA and CAR-T cell therapies are transforming precision medicine, the importance of patient reported outcomes and more.

• Welcome to another exciting episode of Oncology Overdrive 0:14
• About Gandara 0:19
• The interview 1:02
• Can you tell me a little more about what you are working on now? 1:25
• How did you get engaged with the community in Hawaii? 6:30
• What do you think is going to happen with ctDNA moving forward? 8:29
• Can you utilize ctDNA and minimal residual disease information to determine how long patients need to be on adjuvant therapy?11:42
• How did you get into the ctDNA space?15:06
• How do you see AI transforming health care beyond providing patients with more information and taking more ownership of their health?18:28
• Can you tell us more about how a second opinion clinic works? How did this type of clinic develop and become part of what you do?23:17
• What are some of your predictions as to what will happen in oncology care over the next ten to twenty years?29:00
• If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 37:30
• How to contact Gandara 38:47
• Thanks for listening 39:10

David Gandara, MD, is a clinician-scientist and lung cancer specialist internationally recognized for his expertise in thoracic cancers, cancer drug development and biomarker development.